76%
inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą.
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej.
76%
rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą.
Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
76%
inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą.
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej.
76%
rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą.
Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Ackermans & van Haaren NV
Closed
SectorFinance
228 0.97
Overview
Share price change
24h
Min
225.6
Max
228.8
Income | 59M 259M |
|---|---|
Sales | 272M 3.2B |
P/E Sector Avg | 15.946 24.598 |
EPS | 6.121 |
Dividend yield | 1.69 |
Profit margin | 8.217 |
Employees | 24,384 |
EBITDA | 84M 601M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +17.31% upside |
Dividend yield Sector Avg | 1.69% 4.30% |
|---|---|
Next Earnings | 22 maj 2025 |
Market Cap | 1.2B 7.3B |
|---|---|
Previous open | 227.03 |
Previous close | 228 |
News Sentiment
By Acuity
41%
59%
160 / 540 Ranking in Finance
Ackermans & van Haaren NV Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Ackermans & van Haaren NV Forecast
Price Target
By TipRanks
17.31% upside
12 Months Forecast
Average 185 EUR 17.31%
High 185 EUR
Low 185 EUR
Based on 1 Wall Street analysts offering 12 month price targets forAckermans & van Haaren NV - Dist in the last 3 months.
Sentiment
By Acuity
160 / 540 Ranking in Finance
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Ackermans & van Haaren NV
Ackermans & Van Haaren NV engages in marine engineering and contracting, private banking, real estate and senior care, and energy and resources businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; specialized advisory banking services for entrepreneurs and liberal professionals; and financing and financial leasing of cars, equipment, charging stations, and bicycles. The Real Estate & Senior Care segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions; and develops residential, and retail and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital provides engineering and solutions in production process automation; validation and compliance services; production and sale of compact biogas installations; manufactures and supplies specialty chemicals; provides broadcast and media solutions; online and printed news; logistics for rail and road transport, and intermodal transport, and warehousing services; develops new vaccines, and crop and food protection products; and deals and leases commercial vehicles, and distribution of aftermarket products. This segment also develops medical devices; medicines for the treatment of cancer and genetic diseases; and supplies medical equipment and consumables to hospitals through online. The company was founded in 1876 and is based in Antwerp, Belgium.
